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Homelessness is an increasing public health prob-
lem. Because of poor living conditions and limited access 
to healthcare systems, homeless persons are exposed to 
many communicable infections. We summarize the inter-
vention measures reported to be efﬁ  cient for the control and 
the prevention of common transmissible infections among 
homeless populations. Evidence suggests that appropriate 
street- or shelter-based interventions for targeted popula-
tions are the most efﬁ   cient methods. Depending on the 
populations targeted, these interventions may include edu-
cation, free condom distribution, syringe and needle pre-
scription programs, chest radiography screening for tuber-
culosis, directly observed therapy for tuberculosis treatment, 
improvement of personal clothing and bedding hygiene, and 
widespread use of ivermectin for scabies and body louse 
infestation. Systematic vaccination against hepatitis B virus, 
hepatitis A virus, inﬂ  uenza, Streptococcus pneumoniae, and 
diphtheria is strongly recommended. National public health 
programs speciﬁ  c to homeless populations are required.
H
omelessness is an increasing social and public health 
problem worldwide. According to the United Nations, 
“absolute homelessness” describes the conditions of per-
sons without physical shelter. “Relative homelessness” de-
scribes the condition of those who have a physical shelter 
but one that does not meet basic standards of health and 
safety, such as and access to safe water and sanitation, per-
sonal safety, and protection from the elements (1). An es-
timated 100 million persons worldwide experience either 
absolute or relative homelessness (2). Homelessness is 
associated with numerous behavioral, social, and environ-
mental risks that expose persons to many communicable 
infections, which may spread among the homeless and lead 
to outbreaks that can become serious public health concerns 
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(3–8). Epidemiologic studies of homeless populations have 
reported the following prevalence rates for infectious dis-
eases: 6.2%–35% for HIV infection (6,9–13), 17%–30% 
for hepatitis B virus (HBV) infection (9,10), 12%–30% 
for hepatitis C virus (HCV) infection (9,10), 1.2%–6.8% 
for active tuberculosis (TB) (3,4), 3.8%–56% for scabies 
(11,12), 7%–22% for body louse infestation (5,11,13,14), 
and 2%–30% for Bartonella quintana infection (5,15), 
which is the most common louse-borne disease in urban 
homeless.
The prevalence of these transmissible diseases among 
the homeless varies greatly according to living conditions. 
Homeless persons who sleep outdoors in vehicles, aban-
doned buildings, or other places not intended for human 
habitation are mainly street youth, female street sex work-
ers, and persons with mental health problems (1). These 
persons are frequently injection drug users (IDUs), and they 
often engage in risky sexual behavior, which exposes them 
to both blood-borne and sexually transmitted infections 
such as HIV, HCV, and HBV (6,9,10). Homeless persons 
sleeping in shelters are mainly single men, but they also 
include single women, families with children, and mentally 
ill persons (1). The primary health concerns for this popu-
lation are the overcrowded living conditions that expose 
them to airborne infections, especially TB (7), and the lack 
of personal hygiene and clothing changes that expose them 
to scabies, infestation with body lice, and louse-borne dis-
eases (5). Homeless persons using single-room hotels or 
living with friends and family show a high prevalence of 
illicit drug use and risky sexual behavior that increases the 
risk for infections transmitted by blood and/or sex (6), and 
they also frequently live in overcrowded conditions that ex-
pose them to TB (7).
Homeless people face many barriers to accessing 
healthcare systems; these factors contribute to increasing 
the spread of infections (1). Implementing efﬁ  cient strat-
egies to survey and prevent the spread of communicable 
infections among the homeless is a public health prior-
ity. Strategies reported to be efﬁ  cient for controlling or 
preventing communicable infections in the homeless are 
targeted interventions that focus on areas where homeless 
people are more likely to reside and are conducted with a 
mobile team that includes outreach workers (8,16–19). In 
this review, which concentrates on the primary communi-
cable infections commonly associated with homelessness, 
we summarize the main intervention measures reported to 
be efﬁ  cient in controlling and preventing these infections.
Interventions for Homeless at 
Risk for HIV and Hepatitis
The risk for HIV infection is higher in the following 
populations of homeless people: those engaged in sexual 
behavior such as sex work, receptive anal sex, and having 
multiple sexual partners; those who ﬁ  nd it more difﬁ  cult 
to use or obtain condoms (6,10); and those who use drugs 
in shooting galleries or who share syringes or other drug 
paraphernalia (6). Controlling the spread of HIV among 
the homeless requires interventions targeting high-risk 
groups such as youth, female street sex workers, and IDUs 
(16,19,20). For example, an intensive intervention program 
targeting homeless youth achieved a signiﬁ  cant reduction 
of unprotected sex acts over 12 months (p = 0.018) and 
drug use over 12 months (p = 0.019) among female partici-
pants as well as a strong reduction in marijuana use over 
12 months (p = 0.082) in male participants (16). The pro-
gram involved training shelter staff and residents in small 
groups, providing access to health resources, and making 
condoms available easily and at no cost. An interven-
tion program targeting homeless and crack-using African 
American women provided them with psychoeducational 
information and skills training on how to reduce HIV risk 
and drug use; the program signiﬁ  cantly (p = 0.03) reduced 
the number of unprotected sex acts among participants, 
compared with control participants, at 6 months after the 
program was started (19). In Rhode Island, a prescription 
program to deliver syringes to high-risk underserved and 
diverse populations was conducted within the context of 
comprehensive drug treatment. The program recruited 327 
persons and found that 86% saw a physician for syringe 
prescription at least 1 time, 46% at least twice, and 32% 
>3 times; this program demonstrated the feasibility and ac-
ceptability of such a program for and by its target popula-
tion, and it reduced the number of injection drug–related 
risky behavior traits (20).
Factors predisposing to infections with HBV and HCV 
are much the same as those for HIV, with HBV a greater risk 
with of unprotected sex and HCV a greater risk with injec-
tion drug–related behavior (9,10). Therefore, intervention 
measures to prevent the spread of HCV among the home-
less are the same as those noted above for HIV prevention 
(16,19,20). As for HBV infection, some evidence suggests 
that HBV immunizations for the homeless are feasible and 
effective. A study in New Haven, Connecticut, recruited 
212 IDUs at syringe-exchange sites to undergo HBV vac-
cination. Most (63%) were vaccine eligible, including 23% 
of homeless persons; of the vaccine-eligible IDUs, 77% 
completed 2 vaccinations and 66% completed all 3 vac-
cinations (21). Homeless IDUs were more likely than other 
IDUs to complete the vaccination schedule, probably be-
cause the vaccination program and the syringe-exchange 
sites are areas where the homeless tend to congregate, pro-
viding more opportunities for them to access these services. 
An accelerated HBV vaccination schedule should be the re-
gime of choice for homeless people, especially those with a 
past history of drug use. This recommendation is supported 
by a study in the United Kingdom that compared comple-
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tion rates for a conventional HBV vaccine schedule (im-
munization at 0, 1, and 6 months) conducted among home-
less in 1999 with the rates for an accelerated immunization 
schedule (immunization at 0, 7, and 21 days) in 2000. The 
completion rates for the accelerated vaccination regimen 
were almost 7 times higher than rates for the conventional 
one (22). A hepatitis A (HAV) outbreak has been reported 
among homeless persons and IDUs in Bristol (UK), possi-
bly transmitted parenterally (8). The same city is the site of 
a successful HAV vaccination program for homeless per-
sons and drug users to control HAV outbreaks and prevent 
transmission to the wider population (8). In June 2000, this 
program immunized 136 homeless persons and IDUs and 
9 members of staff in shelters, hostels, drug services, and 
drop-in centers. The result was a signiﬁ  cant (p<0.001) drop 
in HAV cases in the Bristol population (including home-
less persons) from 90 cases (January–June) to 33 (July–
December) (8). 
Interventions for Homeless at Risk 
for TB and Airborne Diseases
TB incidence is higher in homeless populations than in 
the general population, as reported in San Francisco (270 
cases/105 persons/year vs. 39.5 cases/105 persons/year) 
(23). Molecular epidemiology studies, using DNA ﬁ  nger-
printing, demonstrated that most TB cases occurring in the 
homeless are primary infections (7,23). The spread of TB 
among the homeless is related to recent person-to-person 
transmission, which produces outbreaks with large clusters 
in which >50% of persons are infected (7). Genotyping 
also identiﬁ  ed homeless shelters as major sites of transmis-
sion (7,23). For example, in Los Angeles, California, from 
March 1994 through May 1999, 3 homeless shelters were 
sites of TB transmission for 55 (70%) of 79 homeless per-
sons. Thirty-six of these 55 persons were infected in 1 large 
shelter in which 595 occupants shared 3 sleeping rooms. 
(7). Common individual risk factors for TB among home-
less persons include alcohol abuse, poor nutrition, and HIV 
infection (4,23). Addiction to injection or inhaled drugs has 
also been reported as associated with TB in the homeless 
(4), but this association remains debated (7,23).
Interventions to control the spread of TB among home-
less persons require early detection of cases and outbreaks 
in shelters, screening of those persons with whom the in-
fectious person has had contact, and effective treatment of 
TB patients. According to a shelter-based screening pro-
gram that used symptom evaluation, chest radiography, and 
in some cases sputum culture and tuberculin skin testing 
(TST), a TB infection rate of 1%–3% has been detected 
among sheltered homeless populations (24,25). Imple-
menting mandatory shelter-based screening in several 
homeless shelters in the United States led to reduction of 
TB transmission among the homeless, as demonstrated by 
the reduction of genotype clustering in DNA ﬁ  ngerprinting 
analyses (17) (Table 1).
No consensus has been reached regarding the most 
effective diagnostic tools for screening for TB among the 
homeless. Logistically, TST is likely to be the simplest 
method to use because it requires only nurses and outreach 
workers (17). It was used successfully to identify TB infec-
tion in several intervention programs (17,24,25). However, 
TST lacks speciﬁ  city, especially in areas where Mycobac-
terium bovis BCG vaccination is common. Spot sputum 
screening is also logistically easy, feasible, and efﬁ  cient 
for identifying unsuspected TB cases in persons in shelters, 
and it can permit rapid detection of patients with smears 
that are acid-fast positive (24,25). However, 50% of TB 
patients’ smears are negative, and the patients may be dif-
ﬁ  cult to locate after culture results are known because the 
homeless tend to be very mobile. Screening by chest radi-
ography either periodically in all residents or speciﬁ  cally in 
symptomatic persons (e.g., chronic coughers) is likely to be 
the most cost-effective approach, as was demonstrated in a 
jail setting (26). This strategy detected 42 cases of TB in 
9,877 homeless persons in Los Angeles (7), and 2 cases of 
active pulmonary TB among 221 persons during a 1-night 
“snapshot” shelter-based survey (see “Snapshot Interven-
tions,” below) in Marseille, France (27).
Screening the contacts made by TB-infected homeless 
persons is more effective when it focuses on possible sites 
of transmission such as homeless shelters rather than when 
it investigates contacts of speciﬁ  c persons. By contrast, 
shelters and housing records are excellent sources of infor-
mation for location-based investigation of contacts (7,23). 
The beneﬁ  ts for screening are clear: a 10% in increase in 
the number of chronically homeless persons with active TB 
who access treatment each year produced a 12.5% decline in 
future TB cases in this population after 10 years compared 
with the number expected without this intervention (28). 
The conditions for effectively treating TB in homeless per-
sons include directly observed therapy (DOT) throughout 
the treatment course to ensure patient compliance and free 
medical care, including extended hospitalization and stays 
in convalescent-care institutions (3,4). Housing-based pro-
grams involving DOT have higher completion rates than 
programs in acute-care hospital settings.
In addition to TB, inﬂ  uenza, pneumococcal pneumo-
nia, and diphtheria have been reported in the homeless 
(29,30). Although no reports on interventions to prevent 
these infections in the homeless have been published, it has 
been suggested that immunization against these diseases 
should be planned and delivered easily and at no cost to 
homeless people since this population is at high risk for 
outbreaks and severe illness (29,30).
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Interventions for Scabies, Body Louse 
Infestations, and Louse-borne Diseases
Scabies is transmitted by person-to-person contact or 
by contaminated fomites (e.g., clothes, bedding). It is more 
prevalent in the homeless than in the general population 
(11). The reported prevalence of scabies varies from 3.8% 
in shelter-based investigations (11) to 56.5% among hos-
pitalized homeless persons (12). Human infestations with 
body lice occur when clothes are not changed or washed 
regularly, and close body-to-body contacts in crowded en-
vironments increase person-to-person transmission of body 
lice (31). In sheltered homeless populations, prevalence 
rates of body lice vary from 7% to 22% (5,11,13,14). In 
very poor hygienic conditions, an infection prevalence of 
80% (18) and a single infected person carrying up to 600 
lice have been reported (14,18). Scabies and body lice in-
festation generate severe pruritus, which leads to scratch-
ing, which may result in bacterial superinfections (11). In 
addition, the body louse is an efﬁ  cient vector for Bartonella 
quintana, Rickettsia prowazekii, and Borrelia recurrentis 
(3,5,15,32). Acinetobacter baumanii has also been isolated 
from lice (32).
Controlling scabies, body louse infestation, and their 
effects on the homeless is a challenge. Classic therapeutic 
measures for scabies are based on bathing, followed by ap-
plication over the entire skin of topical scabicides such as 
permethrin, lindane, benzyl benzoate, and crotamiton (33). 
Treatment with 200 μg/kg ivermectin, 2 doses administered 
2 weeks apart, has been reported to be as effective as a sin-
gle dose of a topical scabicide (33). Treatment of all close 
contacts and housemates is recommended, as well as care-
ful washing of clothing and bedding (33). The therapeutic 
modality recommended for body lice is frequent changing 
and cleaning of clothing, including underwear and socks, as 
well as frequent treatment of bedding with insecticides or 
by boiling the sheets (3,34). In Marseilles, during a 4-year 
study of arthropod-borne infections among homeless peo-
ple, we tried to treat, immediately and systematically, all 
persons in shelters who had scabies or body lice through 
complete clothing change, application of insecticide, ad-
ministration of ivermectin as recommended, and education 
of shelter staff to change and treat the bedding frequently 
(5). Despite these efforts, no signiﬁ  cant decrease in the 
prevalence of scabies and body louse infestation was ob-
served during the study (5). In this population, a reduction 
in the prevalence of body lice infestation was seen after 3 
doses of oral ivermectin were administered at 7-day inter-
vals, but the effect was transient and disappeared by day 
45 (18). In addition, a randomized, double-blind, placebo-
controlled trial was conducted in Marseilles to evaluate 
the effect of a single dose of oral ivermectin on reducing 
the ectoparasite-based pruritus in the sheltered homeless 
population. This study showed that a single dose of oral 
ivermectin transiently reduces pruritus (S. Badiaga, unpub. 
data). These observations suggest that multiple repeated 
treatments of ectoparasite-based pruritus with ivermectin 
are an efﬁ  cient and practical complement to classic thera-
peutic measures like frequent, complete changes of cloth-
ing and bedding to reduce scabies and body lice infestation 
in the homeless.
The most common louse-borne disease reported in the 
urban homeless is Bartonella quintana infection (5).  B. 
quintana is a pathogen restricted to humans and was ﬁ  rst 
described as the agent of trench fever during World War I 
(34). Emergence of B. quintana among the homeless was 
recognized in the early 1990s by simultaneous reports of 
B. quintana endocarditis in 3 homeless persons in France 
(35) and B. quintana bacteremia in 10 homeless persons in 
Seattle, Washington, USA (36). Subsequent epidemiologic 
studies showed B. quintana seroprevalence rates of 2%–
11% among nonhospitalized homeless (5,14,15) and 30% 
in hospitalized homeless persons (15). B. quintana bacter-
emia rates of 5.4% in 930 nonhospitalized homeless per-
sons (5) and 14% in 71 hospitalized homeless persons (15) 
have been reported from Marseilles. B. quintana DNA has 
been identiﬁ  ed in 101 (14.9%) of 678 lice collected from 
the sheltered homeless population in Marseille (5), as well 
as in lice collected from homeless persons in Japan (14).
B. quintana causes trench fever, chronic bacteremia 
that may last up to 78 weeks, endocarditis in alcoholic per-
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Table 1. Communicable infections associated with homelessness*
Specific infections  Transmission route Risk factors for infection spreading References
HIV, hepatitis B, STIs  STIs Sexual risk behavior traits: 
homosexuality/bisexuality, multiple sexual partners, 
crack and/or cocaine use, street sex work 
(6,9,10)
HIV, hepatitis C, hepatitis B, 
hepatitis A 
Blood-borne infections Drug risk behavioral traits: sharing syringe, needle, 
and rinse water
(6,8–10)
Tuberculosis, influenza, diphtheria, 
pneumococcal pneumonia 
Airborne infections  Overcrowding in shelters, alcohol abuse, drug 
addiction, malnutrition, HIV
(3,7,17,23–25)
Scabies, body louse infestation  Skin infections Overcrowding in shelters, lack of personal hygiene, 
poor clothing and bedding hygiene.
(5,11,13–15,18)
Bartonella quintana infection,
epidemic typhus 
Louse-borne infections High prevalence of body louse infestation (5,13–15)
*STIs, sexually transmitted infections. Preventing Diseases in the Homeless
sons without previous valvulopathy, and bacillary angiom-
atosis in HIV-infected persons (34). Chronic bacteremia 
may be identiﬁ  ed by blood cultures in homeless persons 
seen in emergency departments, as reported in a study from 
Marseilles (15). The phenomenon of chronic bacteremia 
suggests that humans are the natural reservoir of B. quin-
tana, as demonstrated by identiﬁ  cation of the bacterium in 
erythrocytes from homeless persons with B. quintana bac-
teremia (37). In addition to delousing, which is the best way 
to prevent louse-borne diseases, antimicrobial drug therapy 
against bacterial agents may be important for eradicating 
reservoirs and preventing complications such as endocardi-
tis in cases of B. quintana infection. A randomized, open, 
placebo-controlled trial demonstrated  signiﬁ  cant efﬁ  cacy 
of doxycycline (200 mg orally once a day for 28 days) in 
combination with gentamycin (3 mg/kg intravenously once 
a day for 14 days) in homeless persons with B. quintana 
chronic bacteremia (38). A regimen of gentamycin for 14 
days and doxycycline for 28 days is recommended for pa-
tients with endocarditis (34).
Epidemic typhus caused by R. prowazekii and relaps-
ing fever due to Borrelia recurrentis are 2 other louse-borne 
diseases that tend to affect the urban homeless. Outbreaks 
of epidemic typhus occur when body louse infestations are 
more prevalent in the population, as observed in Burundi 
(31). To date, no outbreak of epidemic typhus or relapsing 
fever has been observed in the urban homeless, nor has evi-
dence of R. prowazekii or B. recurrentis been found in lice 
collected from this population. Nevertheless, during a 4-year 
study of louse-borne diseases among sheltered homeless 
persons in Marseille, we detected a sporadic acute autoch-
thonous case of epidemic typhus in a sheltered homeless 
person (39) and signiﬁ  cantly higher seroprevalences of R. 
prowazekii antibodies (0.75% vs. 0% in blood donors, p = 
0.05) and of B. recurrentis (1.61% vs. 0% of blood donors, 
p = 0.005) (5). In a massive outbreak of epidemic typhus 
observed in Burundi, doxycycline was efﬁ  cient in control-
ling the outbreak among jail inmates, causing a decrease in 
the death rate from 15% to 0.5% after administration of a 
single dose of 200 mg (Table 2).
Snapshot Interventions
Yearly snapshot interventions in shelters, performed 
by large multidisciplinary teams, have been reported to be 
efﬁ  cient for controlling or preventing infections among the 
homeless (5,11). These investigations can reach a category 
of homeless who do not usually seek healthcare. In Mar-
seilles, since 2000, a large mobile team is sent once a year 
to perform these snapshot interventions in order to survey 
louse-borne disease in the 2 shelters designated for accom-
modating the homeless (5). This team comprises 30–40 per-
sons, including physicians, residents, or fellows; nurses; and 
outreach workers. During interventions, homeless persons 
who choose to participate are interviewed and physically 
examined. Clothes are carefully screened for body lice, and 
speciﬁ  c treatment is given when appropriate. Nurses also 
collect blood and other microbiologic samples for serologic 
tests for louse-, ﬂ  ea-, and tick-borne diseases, as well as 
hepatitis, HIV; and syphilis. Arthropods are collected and 
PCR-screened for pathogens such as Bartonella, the epi-
demic typhus rickettsia, and Borrelia recurrentis. Depend-
ing on the epidemiologic situation, other surveys such as for 
the prevalence of TB and other respiratory diseases can be 
organized (27). In such cases, a pneumologist and radiogra-
phy technologists using a mobile x-ray machine are added 
to the intervention team. These snapshot interventions led 
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Table 2. Interventions to control and prevent the spread of infections in the homeless* 
Infections and specific interventions   References
HIV, HCV, HBV infections 
  Tailored education of targeted population on reducing infection risk with provision of free condoms  (16,19)
  Syringe prescription program and needle exchange programs  (20)
HBV, HAV infections 
  HBV accelerated immunization  (21,22)
 HAV  immunization  (8)
Tuberculosis
  Shelter based-intervention with chest radiograph screening, sputum culture, tuberculin skin testing  (17,24,25,27)
 Genotyping  (7,23)
  Contact investigation through homeless shelters  (7,23)
Influenza, diphtheria, Streptococcus pneumoniae infections 
 Systematic  vaccination 
Scabies, body louse infestation 
  Providing facilities for bathing and laundry; insecticide application to bedding in shelters  (5,34,35)
  Ivermectin for scabies, body louse, and ectoparasite-based pruritus  (18,34)
Louse-borne diseases 
  Doxycycline and gentamicin for persons with chronic Bartonella quintana bacteremia  (39)
  Doxycycline for persons with epidemic typhus  (32)
*HCV, hepatitis C virus; HBV, hepatitis B virus; HAV, hepatitis A virus. PERSPECTIVE
to successively identifying a high prevalence of louse in-
festation, louse-borne diseases such as B. quintana infec-
tion, and skin infections among this homeless population 
(5,11). Snapshot interventions have also identiﬁ  ed the risk 
for the homeless of acquiring other louse-borne diseases 
such as epidemic typhus and relapsing fever, and enabled 
the ﬁ  rst isolation of A. baumanii from lice (5,32,39). This 
strategy of wide systematic testing of infectious diseases in 
this population also led to the unexpected discovery of an 
outbreak of acute Q fever in a homeless shelter in Marseille 
(40). Epidemiologic investigations of this outbreak showed 
that exposure to wind from an abandoned slaughterhouse, 
used for an annual Muslim sheep feast, was the main risk 
factor for developing Coxiella burnetii infection (Figure).
Conclusions
Evidence suggests that appropriate public health in-
terventions can be effective in preventing and controlling 
the spread of numerous transmitted diseases among home-
less persons, which is a public health concern both for the 
homeless and the larger population. These interventions 
should be tailored to the targeted populations and focused 
on areas where the homeless are more likely to reside. The 
strategies reported to be efﬁ  cient include tailored educa-
tion; distribution of free condoms; implementation of a sy-
ringe and needles prescription program for HIV and HCV; 
systematic chest radiography for TB screening in shelters 
and DOT for TB; improvement of personal, clothing, and 
bedding hygiene; use of ivermectin to treat pruritus most 
often caused by scabies or body louse infestation; and im-
munizations against HBV, HAV, inﬂ  uenza, Streptococcus 
pneumoniae, and diphtheria. Implementation of systematic 
vaccination schedules to prevent communicable diseases in 
the homeless is a major public health priority. The success 
of these interventions requires the implementation of a na-
tional public health prevention program for the homeless. 
A yearly snapshot intervention is 1 means to achieve these 
objectives.  
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Now that you’ve read the article, you can listen to the commentary.
Preventing and Controlling Emerging and Reemerging 
Transmissible Diseases in the Homeless
There are an estimated 100 million homeless people worldwide today, and this number 
is likely to grow. The homeless population is vulnerable to many diseases, including HIV, 
hepatitis, and tuberculosis. In this podcast, Dr. Marian McDonald, Associate Director for 
Minority and Women’s Health at CDC, discusses why this population is so vulnerable.